Funds to be used primarily to advance development of ATH434 in Parkinsonian Disorders –– Capital raising was strongly supported by domestic and ...
Alterity Therapeutics (ATHE) has received binding commitments for a capital raising of A$40M via a two tranche placement of fully paid ordinary ...
2-Year U.S. Treasury Note Continuous Contract $102.695-0.027-0.03% 5-Year U.S. Treasury Note Continuous Contract $106.398-0.063-0.06% 10-Year U.S. Treasury Note Continuous Contract $109.156-0.078 ...